Application of degradable piezoelectric scaffold in promotion of nerve cell proliferation and differentiation

By using potassium sodium niobate nanowires with surface modified dopamine and levoligosolate polylactic acid, the degradable piezoelectric scaffolds prepared by using surface modified dopamine, combined with mechanical stress stimulation, the problem of non-degradability and insufficient performance of existing piezoelectric materials in the field of biomedical science is solved, and the problem of insufficient degradability and performance of existing piezoelectric materials in the field of biomedical science is achieved. Effective neuronal cell proliferation and differentiation in biomedical materials.

CN118903561APending Publication Date: 2024-11-08ARTIFICIAL INTELLIGENCE RES INST OF HEFEI COMPREHENSIVE NAT SCI CENT (ANHUI ARTIFICIAL INTELLIGENCE LAB)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410980244.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The application of existing piezoelectric materials in the field of biomedical science is limited by the existence of non-degradable and harmful substances, and their piezoelectric properties in tissue engineering are insufficient, making it difficult to effectively promote the proliferation and differentiation of nerve cells.

Method used

Potassium sodium niobate nanowires with surface modified dopamine and levoligolactic acid are used as degradable piezoelectric scaffolds, and prepared by electrospinning technology, combined with mechanical stress stimulation, and converted into electrical signals to promote the proliferation and differentiation of nerve cells.

Benefits of technology

It has achieved stable piezoelectric performance without reducing cell viability, effectively regulates neural differentiation and proliferation of neural stem cells, and has good biocompatibility and degradability, and is suitable for biomedical materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention provides an application of a degradable piezoelectric scaffold in promoting proliferation and differentiation of nerve cells. The operation of promoting proliferation and differentiation of the nerve cells comprises the following steps: co-culturing the nerve cells and the degradable piezoelectric scaffold, the degradable piezoelectric bracket stimulates proliferation and differentiation of nerve cells by converting stress stimulation into an electric signal; the degradable piezoelectric stent comprises potassium sodium niobate nanowires with the surfaces modified with dopamine and poly-L-lactic acid. The degradable piezoelectric support of the potassium-sodium niobate nanowires with the surfaces modified with dopamine and the poly-L-lactic acid is a piezoelectric nanomaterial which has good biocompatibility and can be biodegraded, the poly-L-lactic acid is a degradable piezoelectric polymer, and by adding the potassium-sodium niobate with good piezoelectric performance, the biodegradable piezoelectric support can be formed. The scaffold material responds to inherent force of cell and body movement and generates an electric signal for stimulating biological tissues, so that neural differentiation and proliferation of neural stem cells are regulated and controlled at the cellular level.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biological scaffolds and piezoelectric materials, and in particular to the application of a degradable piezoelectric scaffold in promoting the proliferation and differentiation of nerve cells. Background Art

[0002] With the development of the trend of population aging, the clinical requirements for biomedical materials are increasing and becoming higher and higher. It is of great significance to research and develop multifunctional electroactive tissue engineering materials. Endogenous electric fields play an important role in embryonic development, wound healing and limb regeneration. The ideal electroactive tissue engineering biomaterial is both a biodegradable regenerative scaffold and a controllable electrical stimulator. Piezoelectric materials can convert mechanical energy into electrical signals and generate current under the action of external forces. In addition, bones and cartilage in organisms also contain these substances. When subjected to stress stimulation, electrical signals will be generated. The application of piezoelectric effect to the field of tissue engineering has broad application prospects.

[0003] Therefore, there is a need to provide a degradable piezoelectric material with good biocompatibility for application in the field of biomedical materials. Summary of the invention

[0004] In view of this, in order to solve at least one of the above problems, the present invention provides an application of a degradable piezoelectric scaffold in promoting the proliferation and differentiation of nerve cells.

[0005] According to an embodiment of the present invention, the operation of promoting the proliferation and differentiation of nerve cells includes:

[0006] Co-culture neural cells with a degradable piezoelectric scaffold, which stimulates the proliferation and differentiation of neural cells by converting stress stimulation into electrical signals;

[0007] Among them, the degradable piezoelectric scaffold includes potassium sodium niobate nanowires and left-rotatory polylactic acid with dopamine modified on the surface.

[0008] According to an embodiment of the present invention, the neural cells include dorsal root ganglion cells and neural stem cells.

[0009] According to an embodiment of the present invention, the neural cells and the degradable piezoelectric scaffold are placed in a culture medium and cultured for at least 7 days; the culture medium includes fetal bovine serum, antibiotics, poly-lysine and nutritional additives required for the growth of neural cells.

[0010] According to an embodiment of the present invention, a method for preparing a degradable piezoelectric support comprises:

[0011] Adding a buffer solution and dopamine hydrochloride into potassium sodium niobate nanopowder to obtain potassium sodium niobate nanowires with surface modified with dopamine;

[0012] The sodium potassium niobate nanowires with surface modification of dopamine and L-polylactic acid are dissolved in solvents respectively, and mixed to obtain an electrospinning mixed solution;

[0013] The electrospinning mixture is prepared into a degradable piezoelectric neural scaffold through an electrospinning device.

[0014] According to an embodiment of the present invention, the solvent is hexafluoroisopropanol.

[0015] According to an embodiment of the present invention, the DC bias voltage of the positive electrode applied by the electrospinning device is 9-11 kV, and the DC bias voltage of the negative electrode is -2.5 kV.

[0016] According to an embodiment of the present invention, the mass ratio of the sodium potassium niobate nanowires with surface modified dopamine to the L-polylactic acid in the electrospinning mixture is (0-10): (20-35).

[0017] According to an embodiment of the present invention, preferably, the mass ratio of the sodium potassium niobate nanowires with surface modified dopamine to the L-polylactic acid in the electrospinning mixture is 3:7.

[0018] According to an embodiment of the present invention, a method for preparing potassium sodium niobate nanopowder comprises the following steps:

[0019] Mixing niobium pentoxide, potassium chloride and potassium carbonate and ball-milling to obtain a first mixed powder;

[0020] The first mixed powder is first calcined to obtain potassium sodium niobate precursor nanowires;

[0021] The potassium sodium niobate precursor nanowires are cleaned and then subjected to a second calcination;

[0022] The second calcined sodium potassium niobate precursor nanowires are mixed and ground with sodium chloride, sodium carbonate, potassium chloride and potassium carbonate to obtain a second mixed powder;

[0023] The second mixed powder is subjected to a third calcination to obtain potassium sodium niobate nanopowder.

[0024] According to an embodiment of the present invention, the temperature of the first calcination is 800-1500° C. and the time is 2.5-3.5 h;

[0025] The second calcination temperature is 500-600°C and the time is 0.5-1.5h;

[0026] The temperature of the third calcination is 800-900°C and the time is 8-12 minutes.

[0027] The molar ratio of niobium pentoxide, potassium chloride and potassium carbonate is (0.5~2):(5~20):(0.5~1.5).

[0028] According to an embodiment of the present invention, the present invention uses a degradable piezoelectric scaffold including potassium sodium niobate nanowires with surface modification of dopamine and L-polylactic acid, wherein the potassium sodium niobate with surface modification of dopamine is a piezoelectric nanomaterial with good biocompatibility and biodegradability, and the L-polylactic acid is a degradable piezoelectric polymer. The good biocompatibility and degradability make the scaffold material not reduce the vitality of cells; by adding potassium sodium niobate with good piezoelectric properties, the scaffold material responds to the inherent force of cell and body movement, generates electrical signals to stimulate biological tissues, and does not require any differentiation-inducing culture medium or components, and can effectively regulate the neural differentiation and proliferation of neural stem cells at the cellular level to achieve the effect of treating and repairing injuries. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] The above and other objects, features and advantages of the present invention will become more apparent through the following description of the embodiments of the present invention with reference to the accompanying drawings, in which:

[0030] Figure 1A This is a scanning electron microscope image of potassium sodium niobate nanowire KNN according to an embodiment of the present invention;

[0031] Figure 1B This is a transmission electron microscope image of potassium sodium niobate nanowire KNN according to an embodiment of the present invention;

[0032] Figure 2A This is a low-resolution scanning electron microscope image of PLLA in an embodiment of the present invention;

[0033] Figure 2B This is a high-resolution scanning electron microscope image of PLLA according to an embodiment of the present invention;

[0034] Figure 3A This is a low-resolution scanning electron microscope image of PLLA / KNN@PDA (30%) of an embodiment of the present invention;

[0035] Figure 3B This is a high-resolution scanning electron microscope image of PLLA / KNN@PDA (30%) of an embodiment of the present invention;

[0036] Figure 4 X-ray diffraction comparison diagram of PLLA, KNN and PLLA / KNN@PDA in the embodiment of the present invention;

[0037] Figure 5A is the open circuit voltage of the PLA piezoelectric thin film nano-power generation device under mechanical force in Comparative Example 1 of the present invention;

[0038] Figure 5B is the open circuit voltage of the PLLA piezoelectric thin film nano-power generation device under mechanical force in Comparative Example 2 of the present invention;

[0039] Figure 5C is the open circuit voltage of the PLA / KNN@PDA (30%) piezoelectric thin film nano-power generation device under mechanical force in Comparative Example 3 of the present invention;

[0040] Figure 5D is the open circuit voltage of the PLLA / KNN@PDA (30%) piezoelectric thin film nano-power generation device under mechanical force in Example 3 of the present invention;

[0041] Figure 6 This is a scanning electron microscope image of the KNN nanowires of the present invention after being immersed in a physiological saline solution for 3 months;

[0042] Figure 7 This is a graph showing the time variation of ion concentration of KNN nanowires immersed in physiological saline solution according to an embodiment of the present invention;

[0043] Figure 8 This is a scanning electron microscope image of the surface morphology change of PLLA / KNN@PDA after immersion in an embodiment of the present invention;

[0044] Fig. 9 This is a comparison chart of the weight loss of PLLA and PLLA / KNN@PDA in PBS after degradation in the embodiment of the present invention;

[0045] Fig.10 This is a graph showing the change of voltage output under mechanical force of PLLA / KNN@PDA over time according to an embodiment of the present invention;

[0046] Fig.11 This is a comparison of live and dead cell staining and cell viability after culturing mouse fibroblasts (L929) on the surfaces of PCL, PLLA and PLLA / KNN@PDA for 3 days in the present invention;

[0047] Fig.12 Comparison of live and dead cell staining and cell viability after culturing chromaffin cells (PC12) on the surfaces of PCL, PLLA and PLLA / KNN@PDA for 3 days in the present invention;

[0048] Fig.13 Comparison of live and dead cell staining and cell viability after culturing neural stem cells (NSCs) on PCL, PLLA and PLLA / KNN@PDA surfaces for 3 days in the present invention;

[0049] Fig.14 This is a comparison of immunofluorescence staining of neural marker proteins Tuj1 and GFAP in promoting NSCs differentiation by PCL, PLLA and PLLA / KNN@PDA in the present invention;

[0050] Fig.15This is a comparison chart of immunofluorescence staining of marker proteins Tuj1, Nestin, GFAP and MAP2 in promoting DRG differentiation by PCL, PLLA and PLLA / KNN@PDA in the examples of the present invention. DETAILED DESCRIPTION

[0051] In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments and with reference to the accompanying drawings.

[0052] Below, embodiments of the present invention will be described with reference to the accompanying drawings. However, it should be understood that these descriptions are exemplary only and are not intended to limit the scope of the present invention. In the following detailed description, for ease of explanation, many specific details are set forth to provide a comprehensive understanding of embodiments of the present invention. However, it is apparent that one or more embodiments may also be implemented without these specific details. In addition, in the following description, descriptions of known structures and technologies are omitted to avoid unnecessary confusion of concepts of the present invention.

[0053] The terms used herein are only for describing specific embodiments and are not intended to limit the present invention. The terms "comprise", "include", etc. used herein indicate the existence of features, steps, operations and / or components, but do not exclude the existence or addition of one or more other features, steps, operations or components.

[0054] All terms (including technical and scientific terms) used herein have the meanings commonly understood by those skilled in the art unless otherwise defined. It should be noted that the terms used herein should be interpreted as having a meaning consistent with the context of this specification and should not be interpreted in an idealized or overly rigid manner.

[0055] In the case of using expressions such as "at least one of A, B, and C, etc.", it should generally be interpreted in accordance with the meaning of the expression generally understood by those skilled in the art (for example, "a system having at least one of A, B, and C" should include but is not limited to a system having A alone, B alone, C alone, A and B, A and C, B and C, and / or A, B, C, etc.). In the case of using expressions such as "at least one of A, B, or C, etc.", it should generally be interpreted in accordance with the meaning of the expression generally understood by those skilled in the art (for example, "a system having at least one of A, B, or C" should include but is not limited to a system having A alone, B alone, C alone, A and B, A and C, B and C, and / or A, B, C, etc.).

[0056] Some of the terms and abbreviations of the present invention are explained as follows:

[0057] PLA: Polylactic acid.

[0058] PLLA: poly (L-lactic acid).

[0059] KNN: potassium sodium niobate.

[0060] PDA: dopamine.

[0061] KNN@PDA: Potassium sodium niobate nanomaterials surface modified with dopamine.

[0062] PLA / KNN@PDA: polylactic acid and potassium sodium niobate piezoelectric scaffolds modified with dopamine on the surface.

[0063] PLLA / KNN@PDA: piezoelectric scaffold of poly (L-lactic acid) and potassium sodium niobate modified with dopamine on the surface.

[0064] Piezoelectric materials have the ability to self-generate electricity under mechanical stress and can be used as self-powered electrical stimulators in a wide range of biomedical applications, including implantable sensors, ultrasonic transducers, and actuators. In the field of tissue engineering, piezoelectric materials have demonstrated their ability to regenerate bones, cartilage, skeletal muscle, skin, and nerves.

[0065] Piezoelectric materials are smart materials that generate electrical signal energy under external force. They can be used as self-powered scaffolds for neural tissue engineering to promote nerve growth, proliferation and differentiation by in situ stimulation of human movement or external mechanical vibration. For example, after polarization, scaffolds made of polyvinylidene fluoride (PVDF) are conducive to the adhesion and growth of myoblasts because of its negative surface charge. Electrospinning polyvinylidene fluoride-trifluoroethylene (PVDF-TrFE) and barium titanate (BaTiO3) to prepare a flexible membrane for wound healing reduced the animal recovery time from 14 days to 9 days. For example, nanostripe array structures were fabricated on PVDF biointerfaces to increase cell adhesion, and nanopillar array PVDF membranes can regulate the adhesion, proliferation and migration of rat bone marrow mesenchymal stem cells (rBMSCs). However, such traditional piezoelectric materials are subject to non-degradability (such as PVDF) or the presence of harmful substances, such as lead zirconate titanate (PZT). Therefore, the application potential of these piezoelectric materials in tissue engineering is limited.

[0066] As a piezoelectric material, PLLA has weaker piezoelectric properties than traditional inorganic piezoelectric materials, which limits the further application of PLLA in the field of energy collection. Inorganic piezoelectric nanomaterials have good piezoelectric properties, but the bulk ceramics are hard and the processing and thinning process is complicated, which is not suitable for the preparation of flexible electronic devices. In order to solve the performance deficiencies of organic piezoelectric polymers and inorganic piezoelectric materials in flexible piezoelectric materials, it was found in the process of realizing the concept of the present invention that the addition of degradable KNN piezoelectric nanomaterials with high piezoelectric properties into the PLLA polymer matrix induces the formation of β phase, which is conducive to the development of high-performance degradable composite piezoelectric materials.

[0067] According to an embodiment of the present invention, there is provided an application of a degradable piezoelectric stent in promoting the proliferation and differentiation of nerve cells. The operation of promoting the proliferation and differentiation of nerve cells includes:

[0068] Co-culture neural cells with a degradable piezoelectric scaffold, which stimulates the proliferation and differentiation of neural cells by converting stress stimulation into electrical signals;

[0069] Among them, the degradable piezoelectric scaffold includes potassium sodium niobate nanowires and left-rotatory polylactic acid with dopamine modified on the surface.

[0070] According to an embodiment of the present invention, PLLA is an α crystal with a helical polymer, which is non-polar under normal conditions. Under stretching or electric polarization, the α crystal may be converted into a β crystal. Potassium sodium niobate (KNO) composed of non-toxic potassium, sodium and niobium 0.5 Na 0.5 NbO3, KNN) is a soluble inorganic material with excellent piezoelectric properties, which may be biodegraded in a physiological environment. Adding potassium sodium niobate nanofillers as nucleating agents to PLLA-based polymers can effectively increase the generation of β phase and improve the piezoelectric properties of composite piezoelectric materials. Using piezoelectric polymers and biodegradable high-performance piezoelectric nanomaterials as piezoelectric scaffolds for neural cell culture not only improves the piezoelectric properties of composite piezoelectric materials, but also slows down the degradation of piezoelectric materials, and can achieve stable piezoelectric properties within a certain period of time. In this way, the neural differentiation of neural stem cells is regulated at the cellular level, thereby achieving the purpose of treating and repairing injuries.

[0071] According to an embodiment of the present invention, the neural cells include dorsal root ganglion cells and neural stem cells.

[0072] According to the embodiments of the present invention, the degradable piezoelectric stent of the present invention can be used to stimulate dorsal root ganglion cells and neural stem cells to proliferate and differentiate, and the stress stimulation is converted into electrical signals to stimulate the cells to achieve the effects of proliferation and differentiation.

[0073] According to an embodiment of the present invention, the stress stimulation of the present invention can be provided by an exciter, for example, the exciter can be driven to generate a constant force to trigger the degradable piezoelectric scaffold to generate an electrical signal. According to an embodiment of the present invention, the nerve cells and the degradable piezoelectric scaffold are placed in a culture medium and cultured for at least 7 days; the culture medium includes fetal bovine serum, antibiotics, poly-lysine and nutritional additives required for the growth of nerve cells.

[0074] According to an embodiment of the present invention, neurogenic cells or neural stem cells require at least 7 days to proliferate and differentiate; the culture medium is a liquid culture medium, in which fetal bovine serum is added for cell growth, maintenance and nutrition; antibiotics are added to avoid bacterial infection during the culture process that affects cell activity; polylysine is added to increase the cell's wall adhesion so that it can better adhere to the surface of the piezoelectric bracket; during the cell culture process, there is no need to add differentiation-promoting substances or use differentiation-inducing culture medium, and the proliferation and differentiation of neural cells are promoted only through the electrical stimulation of the piezoelectric bracket.

[0075] According to an embodiment of the present invention, a method for preparing a degradable piezoelectric support comprises the following steps S1 to S3:

[0076] Step S1: adding a buffer solution and dopamine hydrochloride to the potassium sodium niobate nanowires to obtain the potassium sodium niobate nanowires with surface modified with dopamine;

[0077] Step S2: dissolving the sodium potassium niobate nanowires with surface modified dopamine and L-polylactic acid in solvents respectively, and mixing them to obtain an electrospinning mixed solution;

[0078] Step S3: preparing the electrospinning mixture into a degradable piezoelectric neural scaffold through an electrospinning device.

[0079] According to the embodiments of the present invention, potassium sodium niobate is a soluble inorganic material with excellent piezoelectric properties, which can achieve stable piezoelectric properties within a certain period of time, can be biodegraded in a physiological environment, can be degraded in the body after 8 weeks, and has no toxic side effects on the body. Although PLLA has piezoelectric properties, its piezoelectric properties are lower than those of inorganic piezoelectric materials. Adding potassium sodium niobate nanofillers as nucleating agents to PLLA-based polymers can effectively improve the generation of β phases and improve the piezoelectric properties of composite piezoelectric materials. PLLA is a polymer material with good biodegradability and biocompatibility. PLLA can be gradually decomposed into carbon dioxide and water in the body, which will not pollute the environment. PLLA has good compatibility with biological tissues and will not cause obvious immune reactions or toxic side effects.

[0080] According to an embodiment of the present invention, electrospinning is a technology that simultaneously performs mechanical stretching and electric polarization, which can effectively orient the PLLA molecular segments, increase the electric dipole moment in the PLLA, increase the β-phase content in the nanofibers, and help improve the piezoelectric properties of the PLLA. Therefore, the PLLA piezoelectric nanofiber film obtained by electrospinning technology has good piezoelectric properties.

[0081] According to an embodiment of the present invention, the solvent is hexafluoroisopropanol.

[0082] According to an embodiment of the present invention, hexafluoroisopropanol is used as a solvent that can dissolve a variety of biomaterials and has good chemical stability, which helps to maintain the chemical structure and biological activity of the PLLA polymer. Hexafluoroisopropanol has little effect on the biocompatibility of biomaterials and is suitable for the production of nanofibers for biomedical applications. It can make the spun fibers have good continuity, which will occur intermittently when using other organic solvents.

[0083] According to an embodiment of the present invention, the DC bias voltage of the positive electrode applied by the electrospinning device is 9-11 kV, and the DC bias voltage of the negative electrode is -2.5 kV.

[0084] According to an embodiment of the present invention, the DC bias voltage of the positive electrode applied by the electrospinning device can be 9 kV, 9.5 kV, 10 kV, 10.5 kV, or 11 kV, but is not limited to the listed values, and other unlisted values ​​within the numerical range are also applicable.

[0085] According to an embodiment of the present invention, the high voltage of the positive electrode and the relatively low voltage of the negative electrode work together to generate a strong electric field, which is sufficient to overcome the surface tension of the polymer solution and spray the solution into filaments; due to the voltage difference between the positive and negative electrodes, the electric field strength reaches a maximum near the spinneret, which helps to form a stable jet stream.

[0086] In some embodiments of the present invention, the solvent and voltage parameters are adjusted during the spinning process. The continuity of the spinning can be observed with the aid of light. When the voltage is adjusted in the range of 9kV to 11kV, the nanofibers are continuous and smooth. When the coordinated parameters of other voltages and solvents are selected, the spinning is intermittent or uneven in thickness. Therefore, the optimal parameters of the present invention are determined by the selected solvent and voltage adjustment, rather than simply selecting a certain voltage range and a certain solvent.

[0087] According to an embodiment of the present invention, the mass ratio of the sodium potassium niobate nanowires with surface modified dopamine to the L-polylactic acid in the electrospinning mixture is (0-10): (20-35).

[0088] According to an embodiment of the present invention, the mass ratio of KNN@PDA to PLLA can be 1:20, 1:25, 1:35, 5:20, 5:25, 5:35, 10:20, 10:25, 10:35, but is not limited to the listed values, and other unlisted values ​​within the numerical range are also applicable.

[0089] According to an embodiment of the present invention, with the addition of KNN@PDA, the piezoelectric properties of the composite nanofiber membrane increase. If the added amount is too little, the piezoelectric performance is poor. If the added amount is excessive, it is not suitable for the preparation of flexible electronic devices because of its high hardness as an inorganic material bulk ceramic and the complex processing and thinning process. It will cause the manufactured piezoelectric bracket to become brittle and broken.

[0090] According to an embodiment of the present invention, the mass ratio of the sodium potassium niobate nanowires with surface modified dopamine to the L-polylactic acid in the electrospinning mixture is preferably 3:7.

[0091] The best effect can be achieved when the addition mass ratio of KNN@PDA is 3:7.

[0092] According to an embodiment of the present invention, the weight ratio of the potassium sodium niobate nanowires with surface modified dopamine in the electrospinning mixture is 30%, that is, the mass ratio of KNN@PDA:PLLA is 3:7.

[0093] According to an embodiment of the present invention, when the doping amount exceeds 30%, the composite nanofiber membrane becomes brittle due to increased defects and breaks occur, which reduces the piezoelectric performance of the composite piezoelectric nanofiber membrane. Therefore, selecting 30% as the doping amount of KNN@PDA can ensure that the piezoelectric performance is relatively excellent and the material of the piezoelectric bracket is not too brittle and easy to break.

[0094] According to an embodiment of the present invention, the method for preparing potassium sodium niobate nanopowder comprises the following steps S101-S105:

[0095] Step S101: mixing niobium pentoxide, potassium chloride and potassium carbonate and ball-milling them to obtain a first mixed powder;

[0096] Step S102: performing a first calcination on the first mixed powder to obtain potassium sodium niobate precursor nanowires;

[0097] Step S103: washing the sodium potassium niobate precursor nanowires and then performing a second calcination;

[0098] Step S104: mixing and grinding the second calcined sodium potassium niobate precursor nanowires with sodium chloride, sodium carbonate, potassium chloride and potassium carbonate to obtain a second mixed powder;

[0099] Step S105: performing a third calcination on the second mixed powder to obtain potassium sodium niobate nanowires.

[0100] According to the embodiment of the present invention, the crystal phase, particle size and morphology of the potassium sodium niobate nanopowder prepared by three different calcinations are more suitable for the subsequent production of piezoelectric brackets, ensuring the uniformity and purity of the powder.

[0101] According to an embodiment of the present invention, the temperature of the first calcination is 800-1500° C. and the time is 2.5-3.5 h;

[0102] The second calcination temperature is 500-600°C and the time is 0.5-1.5h;

[0103] The temperature of the third calcination is 800-900°C and the time is 8-12 minutes.

[0104] The molar ratio of niobium pentoxide, potassium chloride and potassium carbonate is (0.5~2):(5~20):(0.5~1.5).

[0105] According to an embodiment of the present invention, the first calcination temperature may be 800°C, 900°C, 1000°C, 1100°C, 1200°C, 1300°C, 1400°C, 1500°C, but is not limited to the listed values, and other values ​​not listed in the numerical range are also applicable. The time may be 2.5h, 3h, 3.5h, but is not limited to the listed values, and other values ​​not listed in the numerical range are also applicable.

[0106] According to an embodiment of the present invention, the second calcination temperature may be 500°C, 520°C, 550°C, 570°C, or 600°C, but is not limited to the listed values, and other values ​​not listed within the numerical range are also applicable. The time may be 0.5h, 1h, or 1.5h, but is not limited to the listed values, and other values ​​not listed within the numerical range are also applicable.

[0107] According to an embodiment of the present invention, the third calcination temperature may be 800°C, 820°C, 850°C, 870°C, 800°C, but is not limited to the listed values, and other values ​​not listed within the numerical range are also applicable. The time may be 8min, 10min, 12min, but is not limited to the listed values, and other values ​​not listed within the numerical range are also applicable.

[0108] The methods described in the following examples are all conventional methods unless otherwise specified, and the reagents and raw materials used can be obtained from public commercial channels unless otherwise specified.

[0109] Example 1 Preparation of potassium sodium niobate nanowires KNN

[0110] Synthesis of potassium sodium niobate nanowires:

[0111] Step S101: weighing raw materials of niobium pentoxide, potassium chloride and potassium carbonate according to a molar ratio of 1:15:1, wet-milling for 1 hour, and drying to obtain a first mixed powder.

[0112] Step S102: calcining the first mixed powder at 1000° C. for 3 hours, i.e., the first calcination, and washing the product with deionized water for multiple times and then drying to obtain potassium sodium niobate precursor nanowires.

[0113] Step S103: Take the potassium sodium niobate precursor nanowires, add them into a nitric acid solution, stir at room temperature or under heating for 48 hours, then wash with hot deionized water until the washing liquid becomes neutral, then dry and calcine at 550° C. for 1 hour, i.e., the second calcination.

[0114] Step S104: weighing the second calcined sodium potassium niobate precursor nanowires, sodium carbonate, potassium carbonate, potassium chloride, and sodium chloride at a mass ratio of 1:3.5:3.5:0.34:0.3, and mixing them to obtain a second mixed powder.

[0115] Step S105: calcining the second mixed powder at 850°C for 10 min, i.e., the third calcination, washing the calcined product with hot deionized water and drying it to obtain potassium sodium niobate nanowires KNN, and characterizing them. The results are as follows: Figure 1A and Figure 1B shown.

[0116] Figure 1A This is a scanning electron microscope image of the potassium sodium niobate nanowire KNN according to an embodiment of the present invention.

[0117] Figure 1B This is a transmission electron microscope image of the potassium sodium niobate nanowire KNN according to an embodiment of the present invention.

[0118] according to Figure 1A and Figure 1B It can be seen that the synthesized potassium sodium niobate nanowires have achieved controllable growth and have the structural characteristics of nanowires and high crystallinity, which helps to improve their piezoelectric properties.

[0119] Example 2 Preparation of PLLA / KNN@PDA degradable piezoelectric scaffold

[0120] Step S1: 1 g of the KNN nanowires prepared in Example 1 was dispersed in 200 mL of 1 mM Tris-HCl aqueous solution at pH 8.6 and ultrasonically treated for 1 h. Then 0.10 g of dopamine hydrochloride was added and vigorously stirred at room temperature for 6 h. Finally, the mixture was centrifuged at 6000 rpm for 10 min and dried in a vacuum oven at 60°C for 12 h to obtain surface-modified KNN nanowires, i.e., KNN@PDA nanowires.

[0121] Step S2: Prepare PLLA / KNN@PDA piezoelectric nanofiber membrane PLLA / KNN@PDA using commercial electrospinning equipment and a high-speed collection device.

[0122] Step S3: Take 0.3g KNN@PDA nanowires and evenly disperse them in 5mL hexafluoroisopropanol, and take 1g PLLA and dissolve it in 10mL hexafluoroisopropanol. After ultrasonicating the two for 30mins, magnetic stirring is performed at room temperature to form a uniform and transparent electrospinning mixture.

[0123] Step S4: The electrospinning mixture was loaded into a 5 mL plastic syringe with a No. 25 stainless steel needle and the electrospinning device was started. The positive electrode of the power supply was connected to the needle and a DC bias of about 10 kV was applied; the negative electrode of the power supply was connected to a collection device wrapped in aluminum foil and a DC bias of -2.5 kV was applied. All experiments were carried out at room temperature, and the thickness of the electrospinning membrane was controlled by adjusting the spinning time. This piezoelectric scaffold containing 30% by weight of KNN@PDA nanowires, i.e., a mass ratio of KNN@PDA:PLLA of 3:7, was labeled as PLLA / KNN@PDA (30%). The preparation process of PLLA / KNN@PDA piezoelectric scaffolds with different KNN@PDA nanowire mass ratios (10% and 40%) was similar.

[0124] PLLA was characterized, and the characterization results were as follows Figure 2A and Figure 2B As shown; PLLA / KNN@PDA (30%) was characterized, and the characterization results are shown Figure 3A and Figure 3B shown.

[0125] Figure 2A This is a low-resolution scanning electron microscope image of PLLA in an embodiment of the present invention; Figure 2B 1 is a high-resolution scanning electron microscope image of PLLA according to an embodiment of the present invention.

[0126] Figure 3A This is a low-resolution transmission electron microscopy image of PLLA / KNN@PDA (30%) according to an embodiment of the present invention; Figure 3B This is a high-resolution electron microscope image of PLLA / KNN@PDA (30%) according to an embodiment of the present invention.

[0127] according to Figure 2A , Figure 2B , Figure 3A and Figure 3B It can be seen that after the addition of KNN@PDA, the pores and morphology of the scaffold material have changed. Through the high-magnification scanning electron microscopy image, it can be seen that there are KNN particles in PLLA.

[0128] X-ray diffraction (XRD) tests were performed on PLLA, KNN and PLLA / KNN@PDA (30%), and the results were as follows: Figure 4 shown.

[0129] Figure 4 1 is a comparison chart of X-ray diffraction of PLLA, KNN and PLLA / KNN@PDA according to the embodiments of the present invention.

[0130] according to Figure 4 It can be seen that the strong characteristic absorption peak of KNN appears in PLLA, indicating that KNN is composited with PLLA.

[0131] Example 3 Output experiment of PLLA / KNN@PDA degradable piezoelectric scaffold under uniform mechanical force

[0132] Preparation of PLLA / KNN@PDA thin film nano-power generation devices:

[0133] A 15 nm thick gold (Au) electrode layer was plated on both sides of the PLLA / KNN@PDA piezoelectric support, and then two copper wires with a diameter of 100 μm were used as the wiring of the nanogenerator. A commercial PU waterproof film was used as the encapsulation layer to protect and insulate the PLLA / KNN@PDA piezoelectric nanofiber membrane (length × width × thickness, 15 mm × 15 mm × 60 µm).

[0134] The drive exciter generates a constant force to simulate the in vitro mechanical force to trigger the piezoelectric film power generation device, and the force gauge is connected to the generator to fit the connection between the local force stimulation and the mechanical energy-electrical energy conversion between the piezoelectric film power generation device. The mechanical force output system is mainly composed of a function generator, a power amplifier, an exciter and a force sensor. The function generator is a multi-waveform signal source that can generate sine waves, square waves and even arbitrary waveforms. A sine wave with a frequency of 10 Hz is programmed through the function generator, and after being amplified by the power amplifier, the exciter is driven to generate a mechanical force of a constant frequency. The nano-power generation device is fixed on the surface of the force sensor. After the exciter is aligned with the surface of the force sensor, the nano-power generation device is facing the center of the ultrasonic transducer. The exciter hits the surface of the nano-power generation device vertically. The output voltage and current of the nano-power generation device are measured by an oscilloscope and a current amplifier. The results are shown in Figure 5D shown.

[0135] Comparative Example 1

[0136] The open circuit voltage of the PLA material under mechanical force was tested using the same method as in Example 3, with an applied pressure of 1 kPa and a frequency of 10 Hz. The results are as follows: Figure 5A shown.

[0137] Comparative Example 2

[0138] The open circuit voltage of the PLLA material under mechanical force was tested using the same method as in Example 3, with an applied pressure of 1 kPa and a frequency of 10 Hz. The results are as follows: Figure 5B shown.

[0139] Comparative Example 3

[0140] The open circuit voltage of PLA / KNN@PDA (30%) material under mechanical force was tested using the same method as in Example 3, with an applied pressure of 1 kPa and a frequency of 10 Hz. The results are as follows: Figure 5C shown.

[0141] Figure 5A The open circuit voltage of the PLA piezoelectric thin film nano-power generation device under mechanical force in Comparative Example 1 of the present invention; Figure 5B The open circuit voltage of the PLLA piezoelectric thin film nano-power generation device under mechanical force in Comparative Example 2 of the present invention; Figure 5C The open circuit voltage of the piezoelectric thin film nano-power generation device of the comparative example 3PLA / KNN@PDA (30%) of the present invention under mechanical force; Figure 5D It is the open circuit voltage of the PLLA / KNN@PDA (30%) piezoelectric thin film nano-power generation device under mechanical force in Example 3 of the present invention.

[0142] according to Figure 5A to Figure 5D It can be seen that doping with KNN can effectively enhance the output performance and piezoelectric properties of the composite film, and under the same KNN doping amount, the piezoelectric performance of PLLA is better than that of PLA.

[0143] Example 4 Comparative characterization of the degradation properties of KNN nanowires, PLLA and PLLA / KNN@PDA

[0144] Degradation experiment of KNN nanowires: 1g KNN nanowires were immersed in 30 mL PBS and shaken continuously at 37℃. The degraded samples were centrifuged and the supernatant was replaced with fresh PBS every week for 6 months. The surface morphology of KNN nanowires before and after immersion was observed by scanning electron microscopy and the changes in their crystal structure were characterized by XRD. The results are shown in Figure 2. Figure 6 shown.

[0145] KNN nanowire ion release experiment: 1g KNN nanowire was immersed in 10 mL of saline solution (9 mg / L sodium chloride solution) and shaken continuously at 37°C. The suspension was centrifuged at 7000 rpm for 10 minutes, and the supernatant was collected and replaced with fresh saline every week until the 8th week. The Na in the supernatant was detected by inductively coupled plasma emission spectrometry (ICP-MS: Perkin Elmer NexION300X, USA). + , K + and Nb 5+ The concentration of cations is shown in Figure 7 shown.

[0146] Figure 6This is a scanning electron microscope image of the KNN nanowires according to an embodiment of the present invention after being immersed in a physiological saline solution for 3 months.

[0147] Figure 7 This is a graph showing the time variation of ion concentration of the KNN nanowires according to an embodiment of the present invention when immersed in a physiological saline solution.

[0148] according to Figure 6 and Figure 7 It can be seen that KNN nanowires can be degraded in a physiological saline environment, and the degradation rate is uniform, showing good biodegradability.

[0149] Degradation comparison experiment of PLLA and PLLA / KNN@PDA: 1g PLLA and 1g PLLA / KNN@PDA piezoelectric scaffolds were immersed in PBS for 6 months, and shaken continuously at 37℃. The surface morphology of PLLA / KNN@PDA after immersion was observed by scanning electron microscopy. The results are shown in Figure 2. Figure 8 Shown

[0150] The PBS was replaced weekly and the PLLA and PLLA / KNN@PDA were dried and weighed to calculate the mass loss of PLLA and PLLA / KNN@PDA. The weight loss percentage of each sample was calculated according to the formula: weight loss % = (W1 - W2) / W1 × 100%, where W1 is the initial weight and W2 is the final weight. The results are shown in Fig. 9 shown.

[0151] During the above process, a portion of the piezoelectric film was taken out at regular intervals for drying to make a PLLA / KNN@PDA thin film nano-power generation device. The output of the device under mechanical force before and after degradation was measured and compared. Fig.10 shown.

[0152] Figure 8 This is a scanning electron microscope image of the surface morphology changes of PLLA / KNN@PDA after immersion in an embodiment of the present invention.

[0153] Fig. 9 This is a comparison chart of the degradation loss weight of PLLA and PLLA / KNN@PDA in PBS according to the embodiment of the present invention.

[0154] Fig.10 This is a graph showing how the voltage output of PLLA / KNN@PDA under mechanical force changes over time according to an embodiment of the present invention.

[0155] according to Figure 8 and Fig. 9It can be seen that the degradation rates of PLLA / KNN@PDA in the early stage of the degradation process are similar, indicating that the fusion of PLLA and KNN is relatively good, the surface is relatively dense, and it is not easy to break. In addition, it can be seen from the scanning electron microscope that there is no breakage.

[0156] according to Fig.10 It can be seen that PLLA / KNN@PDA can exhibit good and stable piezoelectric properties within 2 months, and gradually decreases as it degrades in the body after 2 months. Although it continues to degrade in the body, the change in piezoelectric performance is steadily decreasing, and there is no phenomenon of loss of function when it begins to degrade. This proves that PLLA / KNN@PDA can maintain a stable function reduction process while safely degrading in the body.

[0157] Example 5 Biocompatibility experiments of PCL, PLLA and PLLA / KNN@PDA piezoelectric scaffolds

[0158] The cell compatibility of PLLA and PLLA / KNN@PDA nanofibrous membranes was studied using polycaprolactone (PCl) scaffold as a control:

[0159] Cut the scaffold film into 1 × 1 cm 2 Rectangular slices were cut into the film and mouse fibroblasts (L929), chromaffin cell-derived (PC12) cells and neural stem cells (NSCs) were implanted and cultured. The ethanol-sterilized samples were fixed on the bottom of a 24-well cell culture plate, and then L929, PC12 and NSC cells were implanted into the wells of the culture plate, respectively. Calcein-AM and PI staining were used to stain and analyze live and dead cells, and the cytotoxicity of each component in the film was detected. NSCs were implanted into the wells and cultured for 1, 3 and 5 days to allow the cells to adhere to PLLA and PLLA / KNN@PDA.

[0160] Calcein-AM and PI staining were used to stain and analyze live and dead cells, and the cytotoxicity of each component in the membrane was detected. The CCK-8 method was used to detect cell viability. The CCK-8 method measured the OD value at 450 nm and calculated the relative proliferation rate (RGR). RGR=(OD of the experimental group - OD of the blank control group) / (OD of the negative control group - OD of the blank control group) × 100%. The OD value measured by the CCK-8 method was positively correlated with the number of cells. The larger the OD value, the higher the cell viability or proliferation rate on the surface of the material. The cell experiment set up KNN and control groups, with 5 replicates in each group (n=5). The results are shown in the figure. Fig.11 shown.

[0161] Fig.11This is a comparison of live and dead cell staining and cell viability after culturing mouse fibroblasts (L929) on the surfaces of PCL, PLLA and PLLA / KNN@PDA for 3 days in the examples of the present invention.

[0162] Fig.12 This is a comparison chart of live and dead cell staining and cell viability after culturing chromaffin cells (PC12) on the surfaces of PCL, PLLA and PLLA / KNN@PDA for 3 days in the examples of the present invention.

[0163] Fig.13 This is a comparison chart of live and dead cell staining and cell viability after culturing neural stem cells (NSCs) on the PCL, PLLA and PLLA / KNN@PDA surfaces for 3 days in the examples of the present invention.

[0164] according to Fig.11 , Fig.12 and Fig.13 It can be seen that the PLLA / KNN@PDA prepared in the present invention has good biocompatibility with various cells and does not produce biotoxicity, and shows comparable biocompatibility with the currently recognized green and non-biotoxic PCL material.

[0165] Example 6 Experimental study on the effects of PCL, PLLA and PLLA / KNN@PDA on the differentiation of NSCs

[0166] 2 × 10 4 NSCs cells were cultured on a scaffold containing 1% fetal bovine serum (FBS), 1% penicillin-streptomycin (PS), 2 mM L-alanyl-L-glutamine solution (Gluta Max) and 2% B27 (B27 Supplement).

[0167] After 7 days of culture, NSCs were fixed with 4% formaldehyde for NSC differentiation analysis. Fixed NSCs were incubated with Tuj-1 antibody (1:1000, servicebio), Nestin antibody (1:1000, servicebio), MAP2 antibody (1:1000, Abcam) and GFAP antibody (1:1000, servicebio).

[0168] Donkey anti-mouse IgG H&L (Alexa Fluor®555) (1:1000, Abcam, UK) and donkey anti-rabbit IgG H&L (Alexa Fluor®488) (1:1000, Abcam, UK) were used as secondary antibodies. Primary antibody incubation was overnight, secondary antibody incubation was 1 hour, and DAPI staining was performed. Laser scanning confocal microscopy (LSCM) was used to detect NSCs on the scaffold. For each fluorescent marker, the positive staining area of ​​at least 5 images was measured. The fluorescence intensity of the spot was then measured using ImageJ software and further analyzed using GraphPad. The results are shown in Figure 2. Fig.14 shown.

[0169] Fig.14 This is a comparison of immunofluorescence staining of neural marker proteins Tuj1 and GFAP in promoting NSCs differentiation by PCL, PLLA and PLLA / KNN@PDA in the present invention; Fig.14 (A) Comparison of fluorescent staining of the marker protein Nestin and GFAP; (B) Comparison of relative fluorescence intensity of the marker protein Nestin; (C) Comparison of relative fluorescence intensity of the marker protein GFAP; (D) Comparison of relative mRNA expression levels of the marker protein GFAP; (E) Comparison of relative mRNA expression levels of the marker protein Tuj1; (F) Comparison of neurite lengths of neural stem cells.

[0170] according to Fig.14 It can be seen that in the process of PCL, PLLA and PLLA / KNN@PDA promoting the differentiation of NSCs neurons, the fluorescence intensity of Tuj1 and GFAP marker proteins of PLLA / KNN@PDA is higher and significantly different from that of PCL, and significantly different from that of PLLA, indicating that PLLA / KNN@PDA can more effectively promote the further differentiation of neural stem cells into mature neurons or astrocytes.

[0171] Example 7 Experimental study on the effects of PCL, PLLA and PLLA / KNN@PDA on the differentiation of DRG neurons

[0172] Acute Isolation and Culture of Dorsal Root Ganglion (DRG) Cells from Neonatal SD Rats

[0173] Before the experiment begins, you need to prepare an ice box and sterilized surgical instruments. The dissection fluid needs to be placed in an ice box, and the cell culture medium needs to be preheated in a water bath at 37°C.

[0174] The specific experimental steps for acute isolation and culture of neonatal rat DRG cells are as follows: First, the experimental neonatal rats were killed by dislocating the neck, and the back skin was cut open with surgical scissors to remove the thoracolumbar spine. The thoracolumbar spine was dissected into two symmetrical halves along the midline and quickly placed in DMEM dissection fluid. The dorsal root ganglia of the rat lumbar spine were extracted from the dissected halves of the thoracolumbar spine with surgical forceps and immediately placed in another clean culture dish filled with dissection fluid. Under a stereoscope, surgical scissors and surgical forceps were used to cut off the connective tissue on the surface of the dorsal root ganglia. The ganglia with the cleaned surface were taken out and placed in another clean culture dish filled with dissection culture medium. The excess culture medium was sucked out with a pipette, and the ganglia were cut as finely as possible until they were minced meat. The above operations were performed in an ice box. Take 2 ml of DRG cell digestion enzyme preheated to 37 °C and mix with the dorsal root ganglia that have been cut into minced meat and transfer to a 15 mL sterilized centrifuge tube and mix with a pipette. Place the mixed solution in a constant temperature shaker for oscillation digestion, set the temperature to 37 °C and the speed to 170 rpm. Use a pipette to blow the liquid 5-10 times every 5 minutes, and the cell digestion is completed after 20 minutes. Add 3 mL of DMEM cell culture medium containing fetal bovine serum to the centrifuge tube of the digested DRG cells in the clean bench to terminate the digestion. Centrifuge the above digested and separated DRG cell suspension, set the centrifugal force to 1000 g, and the time to 3 minutes. After the centrifugation, remove the supernatant and resuspend the cells with DMEM cell culture medium containing fetal bovine serum. Add the resuspended cell suspension dropwise to a 24-well cell culture plate with a diameter of 12 mm and a glass slide covered with a polylysine-coated bottom.

[0175] To study the effects of PCL, PLLA, and PLLA / KNN@PDA on DRG differentiation, 2 × 10 4DRGs were cultured on hydrogels. For stimulation experiments, NSCs were cultured on piezoelectric films. After 7 days, NSCs were fixed with 4% formaldehyde for differentiation analysis. Fixed NSCs were incubated with Tuj-1 antibody (1:1000, servicebio), Nestin antibody (1:1000, servicebio), MAP2 antibody (1:1000, Abcam), GFAP antibody (1:1000, servicebio), NF200 antibody (1:1000, Abcam), and S100 antibody (1:1000, servicebio). Donkey anti-mouse IgG H&L (Alexa Fluor®555) (1:1000, Abcam, UK) and donkey anti-rabbit IgG H&L (Alexa Fluor®488) (1:1000, Abcam, UK) were used as secondary antibodies. Primary antibody incubation was overnight, secondary antibody incubation was 1 hour, and DAPI staining was performed. Laser scanning confocal microscopy (LSCM) was used to detect NSCs on the scaffolds. The fluorescence intensity of the spot was then measured using ImageJ software and further analyzed using GraphPad. Fig.15 As shown,

[0176] Fig.15 This is a comparison of the immunofluorescence staining of the marker proteins Tuj1, Nestin, GFAP and MAP2 for promoting DRG differentiation by PCL, PLLA and PLLA / KNN@PDA in the present invention. Fig.15 (A) Comparison of fluorescent staining of the landmark protein Nestin and GFAP; (B) Comparison of fluorescent staining of the landmark protein Tuj1 and MAP2; (C) Comparison of relative fluorescence intensity of the landmark protein Nestin; (D) Comparison of relative fluorescence intensity of the landmark protein GFAP; (E) Comparison of relative fluorescence intensity of the landmark protein Tuj1; (F) Comparison of relative fluorescence intensity of the landmark protein MAP2; (G) Comparison of relative mRNA expression levels in the landmark protein Nestin; (H) Comparison of relative mRNA expression levels in the landmark protein GFAP; (I) Comparison of relative mRNA expression levels in the landmark protein Tuj1; (J) Comparison of relative mRNA expression levels in the landmark protein MAP2.

[0177] according to Fig.15 It can be seen that the expression levels of Tuj1, a marker of early neuronal development, Nestin, a marker of neural stem cells, GFAP, a marker of astrocyte protein, and MAP2, a marker of mature neuron protein, in DRG cells cultured with PLLA / KNN@PDA were all higher than those in PCL and PLLA and were significantly different, indicating that PLLA / KNN@PDA can greatly improve the degree of inducing DRG cell differentiation.

[0178] The specific embodiments described above further illustrate the objectives, technical solutions and beneficial effects of the present invention. It should be understood that the above are only specific embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. Application of a degradable piezoelectric scaffold in promoting the proliferation and differentiation of neural cells, wherein: The operation of promoting the proliferation and differentiation of nerve cells comprises: Co-culturing the nerve cells with a degradable piezoelectric scaffold, wherein the degradable piezoelectric scaffold stimulates the proliferation and differentiation of the nerve cells by converting the stress stimulus received into an electrical signal; The degradable piezoelectric support comprises sodium potassium niobate nanowires with surface modified dopamine and L-polylactic acid.

2. The use according to claim 1, wherein: The neural cells include dorsal root ganglion cells and neural stem cells.

3. The use according to claim 1, wherein: The co-culturing of the neural cells and the degradable piezoelectric scaffold comprises: placing the neural cells and the degradable piezoelectric scaffold in a culture medium and culturing them for at least 7 days; The culture medium includes fetal bovine serum, antibiotics, poly-lysine and nutritional additives required for the growth of nerve cells.

4. The use according to claim 1, wherein: The preparation method of the degradable piezoelectric support comprises: adding a buffer solution and dopamine hydrochloride into the potassium sodium niobate nanowires to obtain the potassium sodium niobate nanowires with surface modified dopamine; Dissolving the sodium potassium niobate nanowires with dopamine modified on the surface and L-polylactic acid in solvents respectively, and mixing them to obtain an electrospinning mixed solution; The electrospinning mixture is prepared into the degradable piezoelectric neural scaffold by an electrospinning device.

5. The use according to claim 4, wherein: The solvent is hexafluoroisopropanol.

6. The use according to claim 4, wherein: The DC bias voltage of the positive electrode applied by the electrospinning device is 9-11 kV, and the DC bias voltage of the negative electrode is -2.5 kV.

7. The use according to claim 4, wherein: The mass ratio of the sodium potassium niobate nanowires with surface modified dopamine to the L-polylactic acid in the electrospinning mixture is (0-10): (20-35).

8. The use according to claim 7, wherein: The mass ratio of the sodium potassium niobate nanowires with surface modified dopamine to L-polylactic acid in the electrospinning mixture is 3:

7.

9. The use according to claim 4, wherein the method for preparing the potassium sodium niobate nanowires comprises the following steps: Mixing niobium pentoxide, potassium chloride and potassium carbonate and ball-milling to obtain a first mixed powder; The first mixed powder is subjected to a first calcination to obtain potassium sodium niobate precursor nanowires; The sodium potassium niobate precursor nanowires are cleaned and then subjected to a second calcination; Mixing and grinding the second calcined sodium potassium niobate precursor nanowires with sodium chloride, sodium carbonate, potassium chloride and potassium carbonate to obtain a second mixed powder; The second mixed powder is subjected to a third calcination to obtain potassium sodium niobate nanowires.

10. The use according to claim 9, wherein: The first calcination temperature is 800-1500°C and the time is 2.5-3.5h; The second calcination temperature is 500-600°C and the time is 0.5-1.5h; The third calcination temperature is 800-900°C and the time is 8-12 minutes; The molar ratio of niobium pentoxide, potassium chloride and potassium carbonate is (0.5-2): (5-20): (0.5-1.5).